Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Weir - Hematology > 3.26.14* Plasma Cell Neoplasms > Flashcards

3.26.14* Plasma Cell Neoplasms Flashcards

PPT* Lecture Notes* Reading (Chapter 21)* Pictures

1
Q

paraproteinaemia

A

presence of monoclonal immunoglobulin band (M-protein) in the serum, from a single clone of plasma cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

multiple myeloma

A

a. clinical presentaiton: caused by plasma cell accumulation in the bone marrow, the presence of m-protein in serum and/or urine. Most over 40, peak at 70. Can progress to tissue damage. Often bone pain due to fractures, anemia, recurrent infections (due to deficient Ab production and neutropenia), low Ab (immune paresis)
b. origin- post-germinal center plasma cell and migrate to bone marrow.
c. diagnostic test: CD138, serum free light chain ratio. Bence-Jones protein in the urine (66%). High ESR.
d. PBS: Rouleaux formations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What kinds of tissue damage can arise from myltiple myeloma

A

C- hypercalcemia
Renal impairment
Anemia
bBone disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immunophenotype of plasma cells

A

CD138

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What types of m-proteins are released in multiple myeloma

A

IgG (60%)
IgA (20%)
light chains (20%) only
(but almost all malignant plasma cells release light chains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What causes bone lesions in multiple myeloma?

A

The osteolytic lesions are caused by osteoclast activation resulting from high serum levels of RANKL (receptor activator of nuclear factor-κB (NF-κB) ligand), produced by plasma cells and bone marrow stroma, which binds to activatory RANK receptors on the osteoclast surface.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Monoclonal gammopathy of undetermined significance

A

serum paraprotein may be sometimes be detected without any evidence of myeloma or other underlying disease. over 50 and increasingly common with age. No clinical symptoms and plasma cell numbers are normal (4%) or slightly raised (10%).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

myeloma is

A

terminally differentiated B cell malignancy (monoclonal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What markers will give a bad prognosis in multiple myeloma

A

17p deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what treatment is best for multiple myeloma

A

autologous stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the best way to diagnose amyloidosis?

A

peripheral fat biopsy to check small vessels for amyloid deposits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

*What is an M spike?

A

seen in serum electrophoresis, meaning presence of monoclonal proteins.
(A broad diffuse band for one globulin protein would mean a polyclonal protein).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

*What does an IFE tell you?

A

(immunofixation electrophoresis)

if there is a monoclonal population and what Ab/chain it is.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

*Name the four components of CRAB

A

calcium (hypercalcemia)
renal deficiency
anemia
bone lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

*Describe the mechanism of bone destruction in myeloma.

A

plasma cells in BM secrete cytokines (DKK1) which leads to increase in serum RANKL that activates osteoclasts to break down bone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

*Stage a myeloma with Durie Salmon and ISS.

A

Durie Salmon staging of MM

1: low M protein, normal calcium, normal bone
2: intermediate
3: CRAB, high M protein

ISS staging of MM

1: B2M less than 3.5 and albumin >3.5
2: both B2M and albumin 3.5 and lytic lesions

17
Q

*Name the worst prognostic chromosome abnormality in Myeloma.

A

17p deletion (p53)

(others:
high B2M, bone lesions, renal insufficiency by creatinine, high LDH/CRP due to cell turnover)

18
Q

*What two classifications of new drugs have changed the way we treat myeloma? Mechanism of action?

A

a. IMIDs: cut off stromal support leading to myeloma cell death
b. BORTEZOMIB- proteosome inhibitors: prevents myeloma cells by degrading pro-apoptotic factors, permitting apoptosis.

19
Q

*When is an autologous transplant indicated in myeloma?

A

.

20
Q

*Why do Waldenstrom patients become hyperviscous more commonly than myeloma patients?

A

.

21
Q

*Name three causes of amyloidosis.

A

a. light chain amyloidosis (myeloma or non-myeloma) involves nervous system, heart, GI and liver.
b. transthyretin amyloidosis
c. Amyloidosis AA- due to chronic inflammatory disorders. Renal, hepatic, GI.

22
Q

70 yo AAM comes to your office with arthritis that is getting worse and increased fatigue. Examination is normal. You discover on initial lab evaluation that his hematocrit is 32 and his creatinine is 2.2. His skull Xray shows lytic lesions.

A

.

23
Q

What diagnostic test should I order to screen for myeloma?

A

Serum protein electrophoresis

B2 microglobulin, bone marrow exam, bone xrays all for confirmation

24
Q

Which result would make me want most to treat a paraproteinemia?

A

.

25
Q 
Which of the following is not a cause of amyloid deposits?
Monoclonal serum light chains
Transthyretin
Chronic osteomyelitis
Rheumatoid arthritis
Polyneuropathy
A

polyneuropathy is a complication of amyloidosis, not a cause

26
Q

Myeloma is

A

a. monoclonal plasma cell proliferation

b. mature B cell malignancy

27
Q

What is seen in PBS of myeloma?

A

rouleaux formation (immunoglobulins cause RBCs to adhere)

28
Q

What complications of myeloma lead to renal insufficiency?

A

hypercalcemia

light chain deposition in renal tubules

29
Q

MGUS (monoclonal gammopathy of unknown significance)

A

asymptomatic increase in abnormal protein. Can progress to monoclonal B cell malignancy.
Bone marrow clonal plasma cells <10%

30
Q

Smoldering myeloma

A

more M-protein
bone marrow clonal plasma cells >10%
asymptomatic

31
Q

Beta-2 microglobulin

A

..

32
Q

Which treatment presently provides best survival in Myeloma?

A 
autologous BMT
(although IMID and proteosome inhibitors are new, but will become very important)
33
Q

Which signs are similar in Waldenstrom’s and Myeloma?

A

both cause monoclonal gammopathy

Myeloma
-lytic bone lesions
Waldenstrom's
- lymphadenopathy
- splenomegaly
- cryoglobinemia
34
Q

Waldenstrom’s Macroglobulinemia

A

(low grade lymphoma with excess monoclonal IgM)

a. > 40 yo
b. hepatosplenomegaly and lymphadenopathy
c. Abnormal bleeding because high protein level effects platelet function.
d. Hyperviscosity syndrome

35
Q

What are the clincial features of hyperviscosity syndrome?

A

headache, blurred vision, altered mental status, ataxia

serum viscosity >4

36
Q

Treatment for Waldenstrom’s macroglobulinemia?

A

Bortezomib
Rituximab (CD20, unlike plasma cells)
Autologous BMT
plasmapheresis for hyperviscosity

37
Q

Amyloid treatment

A

Light Chain Amyloid- Myeloma like therapy (bortezomib and BMT)
Transthyretin Amyloid- Liver transplant
AA Amyloid- Treat chronic disease

Weir - Hematology (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions